Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

(−)-Epigallocatechin (EGC) has been used:as a reference standard in high-performance liquid chromatography (HPLC) analysisto analyze its inhibitory effect on α-amylase and α-glucosidase activity to control postprandial hyperglycemia in Diabetes mellitusin cell viability assays to check its efficacy and protection against ferroptosis and iron toxicity in murine pancreatic β-cellsto evaluate its potential anti-inflammatory effects on long-term acute and chronic Pristen-induced arthritisto treat pregnant and nursing mice, on in vitro angiogenesis, proliferation, and movement of endothelial cellsto evaluate its effect on pregnant and nursing mice spleen based on the number and localization of CD4⁺ (cluster of differentiation 4) and CD8⁺ cluster of differentiation 8) cells

Biochem/physiol Actions

(−)-Epigallocatechin (EGC) has proven to be an anti-cancer agent by its inhibitory effects on heregulin-b1 (HRG)-induced migration/invasion in MCF-7 human breast carcinoma cells. It has also shown strong antiviral activity against the herpes simplex virus.

Green tea polyphenol. Anticancer agent. Lower antioxidant activity than EGCG.

General description

(−)-Epigallocatechin is one of the main catechin compounds found in green tea and the most abundant one (~20%), with antioxidant properties.

Packaging

5 mg in glass bottle